Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.
about
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-AnalysisEvaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.Pneumonia in low and middle income countries: progress and challenges.Antibiotic intravenous-to-oral switch guidelines: barriers to adherence and possible solutions.Role of doxycycline in Clostridium difficile infection acquisition.Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.The role of healthcare strategies in controlling antibiotic resistance.The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.Reply to Livorsi and Eckerle.Clostridium difficile infection: an emerging epidemic with more questions than answers.
P2860
Q29543747-C0E4008B-9F41-4D53-988D-D062A45C3D2BQ35100177-5815E433-C12C-44CA-8BA8-58272D6B2DBEQ35149431-3694933C-4901-4733-91C4-B10476013DE8Q35648136-CA9E42D7-7923-46A3-82F4-6D8697D1EBBEQ36735014-4038DAF5-C745-406A-966E-051BFB397DD5Q36888089-06F4F72F-CFBE-44BD-AC71-4F8C4728F886Q37209299-8FD3FCD7-8F47-4B08-8886-C2084362E177Q37515038-FE1C3794-A909-40C2-BAD3-4674F442DFCEQ37650969-684B893A-9280-44FC-B473-D6B02E719D19Q38182161-7F818B34-71F5-4C64-B746-1D5C4AEDF5F3Q38200538-E5E20AF3-4B80-4EAE-92B1-831C18972E74Q39422204-4DDDC408-346B-4BB7-BB72-A8DEA0768521Q42244373-759FF01A-229E-482E-9EF8-1E853F1A16AAQ44216994-319F87BF-CAA8-406C-AC2C-B33AA5AEEC41Q51724809-B6E9E508-E5B2-4400-BD5B-438C85F0B415Q51800173-2CF53214-9D93-4F59-B215-94FDC51E958A
P2860
Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proposed changes to management ...... lostridium difficile epidemic.
@en
Proposed changes to management ...... lostridium difficile epidemic.
@nl
type
label
Proposed changes to management ...... lostridium difficile epidemic.
@en
Proposed changes to management ...... lostridium difficile epidemic.
@nl
prefLabel
Proposed changes to management ...... lostridium difficile epidemic.
@en
Proposed changes to management ...... lostridium difficile epidemic.
@nl
P2093
P2860
P356
P1476
Proposed changes to management ...... lostridium difficile epidemic.
@en
P2093
James D Chalmers
John H Winter
Mudher Al-Khairalla
Philip M Short
Tom C Fardon
P2860
P304
P356
10.1093/JAC/DKQ038
P407
P577
2010-02-23T00:00:00Z